The Solabia Group, with its five research and development centers and nine production units, has a range of complementary know-how enabling it to offer a vast range of active ingredients used worldwide by the cosmetics, pharmaceutical and nutraceutical industries.
Originally specialized in enzymatic hydrolysis, our Group has quickly expanded its activities and know-how through its various acquisitions but also through the development of new technologies within its production units.
Our expertise in biotechnology, fine chemistry, hydrolysis, enzymatic synthesis and marine or vegetal extractions gives us a coherent set of technologies that allow us to respond to and anticipate the expectations of the various sectors in which the Solabia group is present.
The Solabia group attaches particular importance to developing partnerships with its customers. Closer to their needs, its marketing and R&D teams offer turnkey concepts to initiate their new projects and formulation advice to help them in the implementation and positioning of its ingredients.
Our research and development centers bring together dozens of international researchers whose original know-how, a vector of innovation, allows us to have complete mastery of biocatalysis, enzymatic synthesis, fermentation and vegetal extraction techniques.
This complementary know-how allows us to develop innovative products and partnerships with our customers as well as with internationally renowned research organizations. Our Group has 5 complementary research centers (BioEurope, Biokar, Solabia Biotecnologica, Bioactor, AppleChem) with specific know-how and high-level expertise.
Solabia Group has 9 production sites at the cutting edge of technology to serve its various markets and meet its customers’ needs in terms of quality, efficiency, safety and transparency.
Our subsidiaries (Brazil, United States, Germany) and our network of distributors coordinated by our teams ensure the same quality of service on all five continents.
